Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Concord Biotech Community
NSEI:CONCORDBIO Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
Concord Biotech
Popular
Undervalued
Overvalued
Community Investing Ideas
Concord Biotech
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Expansion Into Oncology And Anti-Infectives Will Strengthen Market Position
Key Takeaways Strategic expansion into high-margin markets with new product introductions promises strong long-term revenue growth and improved net margins. Focus on renewable energy and new plant capabilities is enhancing operational efficiency, boosting margins and growth potential.
View narrative
₹1.94k
FV
5.3% undervalued
intrinsic discount
20.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
CONCORDBIO
CONCORDBIO
Concord Biotech
Your Fair Value
₹
Current Price
₹1.83k
19.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
27b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹27.0b
Earnings ₹8.4b
Advanced
Set Fair Value